TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Market Cap

$98M

Revenue

$0

P/E Ratio

N/A

P/B Ratio

0.05

D/E Ratio

0.01

Dividend Yield

0.00%

PEG Ratio

-0.00

Net Income

-$22M

Net Profit Margin

0.00%

Beta

0.2241

Gross Margin

0.00%

R/S Growth

0.00

52W Low

$0.00

52W High

$0.00

Updated: June 30 at 18:42:13